Micro-Cap Biotech Snaps Up Phase 2 Drug Portfolio - Now a Diversified Play

Tiny Healthcare Player Bets Big on Ethereum—Here's the Full Story... ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ Unsubscribe Sponsored content from i2i Marketing Group, LLC Dear Investor, A little-known healthcare company trading around $1 is starting to turn heads. Already active in pharma, nutraceuticals, and telehealth, it just made a bold move that could change its trajectory: adding Ethereum (ETH) to its balance sheet. This unique mix of healthcare growth and crypto exposure has pushed it to the very top of our watchlist. Highlights: Expanding pharma distribution in the U.S. & Europe Fast-growing nutraceutical brand portfolio New global partnerships, including entry into the GCC market Research targeting obesity, diabetes, and cancer Ethereum treasury strategy with access to a $300M facility View Ticker & Full Report Best, StockVerse   This email is a paid advertisement sent on behalf of i2i Marketing Group, LLC, a third-party advertiser of MarketBeat. Why did I get this email content?.     We are not securities dealers or brokers, investment advisers or financial advisers, and you should not rely on the information herein as investment advice. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the profiled company's SEC and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk.     If you have questions or concerns about your account, don't hesitate to email our U.S. based support team at contact@marketbeat.com.   If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.   Copyright 2006-2025 MarketBeat Media, LLC. All rights protected. 345 North Reid Place, Sixth Floor, Sioux Falls, SD 57103. U.S.A..